Science Explorer Back to mapMap
Discussion
Researcher · Centre Pasteur du Cameroun · Cameroon

Sara Irene Eyangoh

Sara Irene Eyangoh publishes mostly in Epidemiology, Infectious Diseases and Surgery, on topics such as Mycobacterium research and diagnosis, Tuberculosis Research and Epidemiology and Infectious Diseases and Mycology.

ORCID 0000-0002-0557-3815 OpenAlex
World rank
#1,728,535
of 7,710,434 ranked researchers
Rank in Cameroon
#331
of 3,319
Works
132
Citations
2.2k
Citations per work
17.0
h-index
29
i10-index 52Top 11% in Epidemiology
Sara Irene Eyangoh

What does Sara Irene Eyangoh research?

Sara Irene Eyangoh's work is mostly in Medicine (64%), Veterinary (7%).

Health Sciences: 93 works · 70.5% of their workMedicine: 84 works · 63.9% of their workEpidemiology: 34 works · 26.0% of their workInfectious Diseases: 29 works · 22.1% of their workSurgery: 10 works · 7.9% of their workPublic Health, Environmental and Occupational Health: 5 works · 4.1% of their workPhysiology: 5 works · 3.8% of their workVeterinary: 9 works · 6.6% of their workSmall Animals: 9 works · 6.6% of their workEverything else: 39 works · 29.5% of their workTHEIR WORKSara IreneEyangoh132works
Health Sciences70%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine8463.9%
    2. Veterinary96.6%
  2. Everything else3929.5%
  1. 1Epidemiology26% of their works
  2. 2Infectious Diseases22% of their works
  3. 3Surgery8% of their works
  4. 4Small Animals7% of their works
  5. 5Public Health, Environmental and Occupational Health4% of their works
  6. 6Physiology4% of their works

Research topics

Which keywords describe Sara Irene Eyangoh's research?

The keywords of their largest research topics: Epidemiology, Diagnosis, Treatment, Antibiotic Resistance, Mycobacterium avium, Nontuberculous Mycobacteria, Vaccine and Mycobacterium tuberculosis.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 22 words, with their numbers
  1. Epidemiology1173 topics
  2. Diagnosis1082 topics
  3. Treatment1082 topics
  4. Antibiotic Resistance752 topics
  5. Mycobacterium avium611 topic
  6. Nontuberculous Mycobacteria611 topic
  7. Vaccine582 topics
  8. Mycobacterium tuberculosis471 topic
  9. Tuberculosis471 topic
  10. Clinical Practice Guidelines242 topics
  11. Oomycetes241 topic
  12. Retroviruses241 topic
  13. Spinal Epidural Abscess151 topic
  14. Tuberculous Meningitis151 topic
  15. Abdominal Tuberculosis141 topic
  16. Diagnostic Challenges141 topic
  17. Neurosyphilis141 topic
  18. Syphilis141 topic
  19. Coronavirus111 topic
  20. SARS-CoV-2111 topic
  21. Community-Acquired Pneumonia91 topic
  22. Pneumococcal Conjugate Vaccine91 topic

Where does Sara Irene Eyangoh work?

Sara Irene Eyangoh's main affiliation in the publication record is Centre Pasteur du Cameroun, Cameroon.

How many publications and citations does Sara Irene Eyangoh have?

OpenAlex counts 132 works and 2,249 citations for Sara Irene Eyangoh, an h-index of 29, ranking #1,728,535 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Sara Irene Eyangoh. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.